Skip to content

Neurocybernetics

Country not established

Devices
1

What Neurocybernetics makes

Neurocybernetics manufactures the NEUROCOMP, a device designed for neurofeedback therapy to monitor and modulate brainwave activity in clinical settings.

The NEUROCOMP is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Neurocomp Ref K993654

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Neurocybernetics have in the registry?

The registry currently lists 1 device for Neurocybernetics. Devices recorded under merged duplicate company entries are counted once.

Which registries list Neurocybernetics's devices?

Among its 1 most recently registered device, Neurocybernetics has devices listed in FDA 510(k) (1 device).

What risk classes do Neurocybernetics's devices fall under?

Among its 1 most recently registered device, the classes recorded for Neurocybernetics's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Neurocybernetics in the registry?

The most recently registered devices listed for Neurocybernetics include NEUROCOMP.

Generated automatically from registry data and not verified by a human reviewer.